Wealthy funder pays reparations for use of HeLa cells
By Alexandra Witze,
Nature
| 10. 29. 2020
Howard Hughes Medical Institute’s six-figure donation is a step towards addressing racial injustice in the sciences.
A major biomedical-research organization has for the first time aimed to make financial reparation for the continuing experimental use of cells from Henrietta Lacks, a Black woman who was the source of the historic ‘HeLa’ cell line, which has been a mainstay of biological research for decades. The Henrietta Lacks Foundation announced the six-figure gift from the Howard Hughes Medical Institute (HHMI) in Chevy Chase, Maryland, on 29 October.
In 1951, doctors took cancerous cells from Lacks without her consent, and later created the HeLa cell line, which today supports a multibillion-dollar biotechnology industry. Lacks died soon after, and for decades, her family saw no financial compensation and were not consulted on other medical decisions stemming from the use of the cells in research.
“We felt it was right to acknowledge Henrietta for the use of HeLa cells and to acknowledge that the cells were gained inappropriately,” says Erin O’Shea, president of the HHMI. “And to acknowledge that we have a long way to go before science and medicine are really equitable.” The HHMI did not disclose the exact amount...
Related Articles
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Rob Stein, NPR | 07.16.2025
Scientists can protect children from being born with certain devastating genetic disorders by creating "three-parent" babies, according to the results of a landmark study released Wednesday.
British researchers used the experimental technique to help families have eight children who appear...